MLchartDataset catalogue

HMR 1275

Term · Oncology and biomedicine · MLC-T-ONC-003937

A substance being studied in the treatment of several types of cancer. It stops cells from dividing and may kill cancer cells. It is a type of cyclin-dependent kinase (CDK) inhibitor. Also called alvocidib and flavopiridol.

Table 1. Record
IdentifierMLC-T-ONC-003937
FieldOncology and biomedicine
Synonymsalvocidib; flavopiridol
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-003937",
  "term": "HMR 1275",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of several types of cancer. It stops cells from dividing and may kill cancer cells. It is a type of cyclin-dependent kinase (CDK) inhibitor. Also called alvocidib and flavopiridol.",
  "synonyms": [
    "alvocidib",
    "flavopiridol"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/hmr-1275/"
}

Record 8,582 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.